Isolators For Pharmacy Compounding – Time For Change?

By Chris Berridge, Senior Global Technical Consultant, Bio-Decontamination Specialist

Patient safety remains the paramount concern in drug compounding. As the complexity of compounded medications increases, so does the imperative for robust contamination control. Isolator systems offer a significant advancement in aseptic processing, creating a physical barrier between the operator and the critical compounding environment. This closed system approach minimizes the risk of introducing viable and non-viable contaminants, safeguarding the integrity of compounded products.

This white paper explores the tangible advantages of isolator technology, including enhanced product quality, improved operator safety, and potential cost efficiencies. We will discuss how these systems facilitate compliance with stringent guidelines, like EU GMP Annex 1, and streamline compounding workflows. Investigate the potential of isolators to elevate your compounding practices and ensure patient well-being.